A Single-center, Open, Randomized, Single-dose, Cross-over Bioequivalence Study to Evaluate the Effects of the Test Formulation Abalparatide Injection and the Reference Formulation Abalparatide Injection (Tymlos®) in Healthy Adult Subjects
Clinical trial NCT06753864 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06753864
- Sponsor
- The Affiliated Hospital of Qingdao University
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-02
- Primary completion
- 2025-01-09
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.